76,106 iShares Biotechnology ETF $IBB Shares Purchased by MinichMacGregor Wealth Management LLC

MinichMacGregor Wealth Management LLC grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3,323.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 78,396 shares of the financial services provider’s stock after acquiring an additional 76,106 shares during the quarter. iShares Biotechnology ETF accounts for 2.8% of MinichMacGregor Wealth Management LLC’s holdings, making the stock its 11th biggest position. MinichMacGregor Wealth Management LLC owned approximately 0.15% of iShares Biotechnology ETF worth $16,505,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Focus Financial Network Inc. raised its stake in shares of iShares Biotechnology ETF by 6.3% during the 3rd quarter. Focus Financial Network Inc. now owns 6,056 shares of the financial services provider’s stock worth $1,275,000 after purchasing an additional 359 shares in the last quarter. B. Riley Wealth Advisors Inc. raised its position in shares of iShares Biotechnology ETF by 87.4% in the third quarter. B. Riley Wealth Advisors Inc. now owns 2,897 shares of the financial services provider’s stock valued at $610,000 after purchasing an additional 1,351 shares during the period. Ulrich Consultants & Investment Group LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth about $423,000. GK Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at about $94,000. Finally, Castle Rock Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF by 33.6% during the third quarter. Castle Rock Wealth Management LLC now owns 1,910 shares of the financial services provider’s stock worth $388,000 after purchasing an additional 480 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB traded up $3.01 on Wednesday, reaching $203.03. The stock had a trading volume of 501,562 shares, compared to its average volume of 1,642,887. The firm has a fifty day moving average of $206.36 and a two-hundred day moving average of $187.17. iShares Biotechnology ETF has a 1-year low of $151.01 and a 1-year high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were paid a $0.0112 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date of this dividend was Tuesday, September 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.